Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis

Type 2 innate lymphoid cells (ILC2) potentiate immune responses, however, their role in mediating adaptive immunity in cancer has not been assessed. Here, we report that mice genetically lacking ILC2s have significantly increased tumour growth rates and conspicuously higher frequency of circulating...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Saranchova, Iryna, Han, Jeffrey, Zaman, Rysa, Arora, Hitesh, Huang, Hui, Fenninger, Franz, Choi, Kyung Bok, Munro, Lonna, Pfeifer, Cheryl G., Welch, Ian, Takei, Fumio, Jefferies, Wilfred A.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5811448/
https://ncbi.nlm.nih.gov/pubmed/29440650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-20608-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires